Updated November 2018
2018-2019 Influenza Vaccine Supply
AAP staff gathers information each year to respond to your concerns about influenza vaccine distribution and delivery. As is the case with influenza, each season is a bit different, so the information shared is specific to this season and will likely change next year. Please know that the AA P will continue to advocate on your behalf, and on the behalf of children, throughout the flu season. This year, the Centers for Diseases Control and Prevention (CDC) Advisory Committee on Immunization Practices recommended that live attenuated influenza virus vaccine (LAIV, Flumist, MedImmune) could be used during the 2018–2019 season (in those for whom the vaccines is appropriate). The AAP also allows use of LAIV, but recommended that Inactivated Influenza Vaccine (IIV) be used when possible.
Influenza Vaccines for the 2018-2019 Influenza Season
Changes from last year's influenza recommendations and vaccine options include the following:
The age recommendation for "Fluarix Quadrivalent" was changed from 3 years old and older to 6 months and older after the annual recommendations were published last season to be consistent with Food and Drug Administration (FDA)-approved labeling.
The age recommendation for Afluria Quadrivalent was changed from 18 years old and older to ≥5 years old and older after the annual recommendations were published last season to be consistent with FDA-approved labeling.
Resources for the 2018-2019 Influenza Season